- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: AZD5718
Total 77 results
-
AstraZenecaCompleted
-
AstraZenecaParexelCompletedCoronary Artery Disease (CAD)United Kingdom
-
AstraZenecaParexelCompletedChronic Kidney DiseaseUnited Kingdom
-
AstraZenecaQuotient SciencesCompletedCardiovascular DiseaseUnited Kingdom
-
AstraZenecaParexelCompletedCoronary Artery DiseaseUnited Kingdom
-
National University Heart Centre, SingaporeAstraZenecaRecruitingAcute Coronary SyndromeAustralia, New Zealand, Singapore
-
AstraZenecaCompletedCoronary Artery DiseaseDenmark, Finland, Sweden
-
AstraZenecaCompletedCardiovascular Disease | Healthy Male SubjectsUnited Kingdom
-
AstraZenecaActive, not recruitingAdvanced Solid TumoursUnited States, France, Spain
-
AstraZenecaCompleted
-
AstraZenecaTerminatedType 2 DiabetesSweden
-
Massachusetts General HospitalAstraZenecaRecruiting
-
Royal Marsden NHS Foundation TrustAstraZeneca; Cancer Research UK; RM/ICR Biomedical Research CentreActive, not recruitingSolid Tumour Refractory to Conventional TreatmentUnited Kingdom
-
AstraZenecaCompletedMild Cognitive Impairment | Mild Alzheimer's DiseaseUnited States
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Sweden, Denmark, Finland, Netherlands, Norway
-
AstraZenecaTerminated
-
AstraZenecaCompletedHigh Risk Coronary Artery DiseaseUnited Kingdom
-
AstraZenecaCompleted
-
AstraZenecaCompletedTourette SyndromeUnited States
-
AstraZenecaParexelRecruitingHealthy Subjects | Crohns DiseaseUnited Kingdom
-
AstraZenecaCompleted
-
CSL BehringCompletedFatigue | NSCLC | CachexiaCanada, Australia, Russian Federation, Georgia, Serbia, India, New Zealand, Poland, Romania
-
AstraZenecaCLL ConsortiumCompletedB Cell Lymphomas | 11q-deleted Relapsed/Refractory Chronic Lymphocytic Leukaemia (CLL), | Prolymphocytic Leukaemia (PLL)United States
-
Daiichi SankyoAvailableEpidermal Growth Factor Receptor (EGFR)-Mutated Non Small Cell Lung CancerUnited States
-
University of Michigan Rogel Cancer CenterTerminatedProstate CancerUnited States
-
CSL BehringTerminatedOral MucositisUnited States, Canada, Australia, Germany, Italy, Austria
-
AstraZenecaRecruiting
-
AstraZenecaCompletedTolerabilityUnited States
-
AstraZenecaCompletedAdvanced Solid Tumours With Androgen Receptor Pathway as a Potential FactorUnited Kingdom, United States
-
AstraZenecaCompletedBrain Distribution of [11C]AZ12807110 and AZD5213Sweden
-
CSL BehringTerminated
-
CSL BehringCompletedArthritis, RheumatoidRussian Federation, Serbia, Georgia, Canada, India, Poland
-
AstraZenecaParexel; George Clinical Pty LtdTerminatedChronic Kidney DiseaseUnited States, Taiwan, Germany, Hungary, Malaysia, Japan, Israel, Poland, Brazil, Ukraine, Argentina
-
Acerta Pharma BVActive, not recruitingChronic Lymphocytic LeukemiaUnited Kingdom, Poland
-
Seoul National University HospitalRecruitingBile Duct Cancer | Chemotherapy EffectKorea, Republic of
-
Se-Hoon LeeAstraZenecaCompletedSmall Cell Lung CancerKorea, Republic of
-
University of NottinghamCompletedInsulin Resistance | Age ProblemsUnited Kingdom
-
AstraZenecaActive, not recruitingNon-Small Cell Lung CancerFrance, Spain, United States, Canada, Korea, Republic of, Austria, Israel, Germany
-
Mette M BergerTexas A&M UniversityCompletedCritical Illness | Muscle WeaknessSwitzerland
-
Samsung Medical CenterActive, not recruitingGastric Adenocarcinoma | Malignant MelanomaKorea, Republic of
-
Samsung Medical CenterCompleted
-
AstraZenecaParexelCompletedCardiovascular DiseaseUnited Kingdom
-
University of PennsylvaniaAstraZeneca; Myriad Genetics, Inc.RecruitingHigh Grade Serous CarcinomaUnited States
-
University of Michigan Rogel Cancer CenterActive, not recruitingProstate CancerUnited States
-
Samsung Medical CenterCompletedRefractory CancerKorea, Republic of
-
AstraZenecaCompletedHead and Neck Squamous Cell CarcinomaTaiwan, United States, France
-
Institute of Cancer Research, United KingdomAstraZeneca; Cancer Research UKRecruitingGynaecological CancersUnited Kingdom
-
Institute of Cancer Research, United KingdomAstraZenecaRecruitingBreast NeoplasmUnited Kingdom